Survivorship Post-HCT Optimization Program

Clinical trial NCT05238376 · COMPLETED

Trial details

NCT number: NCT05238376
Sponsor: Duke University
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Hematologic Malignancy

Start date: 2022-12-02
Primary completion: 2025-02-26
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.